ClinicalTrials.Veeva

Menu

Endourological Management of Stones During COVID19

R

Roxanne Teo

Status

Completed

Conditions

COVID-19
Urolithiasis

Treatments

Procedure: Endourological surgery

Study type

Observational

Funder types

Other

Identifiers

NCT05293262
2020/01298

Details and patient eligibility

About

Guidelines for endourological procedures during COVID-19 have suggested deferring all elective procedures, while obstructed/ infected stones should undergo urgent decompression.

At our centre, screening protocols were implemented with prioritization strategies so that elective care could safely continue at deescalated rates. COVID or septic patients underwent emergency decompression, while non-COVID and non-septic patients underwent primary ureteroscopy (URS) or retrograde intrarenal surgery (RIRS).

We aim to report our experience with endourological surgery for stone disease during COVID-19.

Full description

We conducted a retrospective review of a prospectively maintained database of all endourological surgeries for stones in our centre during the first wave of COVID19.

Enrollment

158 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria

  • all patient with urolithiasis who underwent endourological interventions during COVID19 pandemic

Trial design

158 participants in 1 patient group

Patients who underwent endourological surgery for urolithiasis during COVID19
Description:
Endourological surgery (including ureteral stent insertion, ureteroscopy, retrograde intrarenal surgery)
Treatment:
Procedure: Endourological surgery

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems